← Home
Company Overview | Competitive advantages | Market | Competition | Capital & Finance | Products | Customers | Future Perspectives & Strategy | Stock market | Risks | Innovation | Employees | Operation | Company management | Legal and Regulatory Compliance |
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
DiaSorin
Healthcare & biotech / Biotechnology
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebCompany Overview | Competitive advantages | Market | Competition | Capital & Finance | Products | Customers | Future Perspectives & Strategy | Stock market | Risks | Innovation | Employees | Operation | Company management | Legal and Regulatory Compliance |
Company Overview
General information about the DiaSorin company
DiaSorin is a global company that specializes in the development, production, and distribution of diagnostic tests for the clinical laboratory market. The company was founded in 1968 in Italy and has since expanded to have a presence in over 60 countries. DiaSorin is a leader in the field of immunodiagnostics and molecular diagnostics, with a focus on infectious diseases, autoimmune disorders, and other chronic conditions.
The company's headquarters are located in Saluggia, Italy, and it also has major operations in the United States, China, and other European countries. DiaSorin's products are used in hospitals, laboratories, and research institutions worldwide.
The company's product line includes over 40 diagnostic test systems that are used to detect various diseases and conditions. These tests use a variety of technologies, including enzyme-linked immunosorbent assays (ELISA), chemiluminescence, and polymerase chain reaction (PCR). Some of DiaSorin's most well-known tests include those for detecting HIV, hepatitis, and Lyme disease.
In addition to its diagnostic tests, DiaSorin also offers automated systems that streamline testing processes and improve efficiency in laboratories. The company is committed to innovation and invests heavily in research and development to continually improve and expand its product portfolio.
DiaSorin is committed to sustainability and ethical practices, with a specific focus on employee well-being, environmental impact, and social responsibility. The company also values diversity and inclusivity, with a workforce that represents over 25 different nationalities.
In 2020, DiaSorin's total revenue was over €870 million. The company continues to grow and expand its reach, with a strong commitment to improving healthcare worldwide.
The company's headquarters are located in Saluggia, Italy, and it also has major operations in the United States, China, and other European countries. DiaSorin's products are used in hospitals, laboratories, and research institutions worldwide.
The company's product line includes over 40 diagnostic test systems that are used to detect various diseases and conditions. These tests use a variety of technologies, including enzyme-linked immunosorbent assays (ELISA), chemiluminescence, and polymerase chain reaction (PCR). Some of DiaSorin's most well-known tests include those for detecting HIV, hepatitis, and Lyme disease.
In addition to its diagnostic tests, DiaSorin also offers automated systems that streamline testing processes and improve efficiency in laboratories. The company is committed to innovation and invests heavily in research and development to continually improve and expand its product portfolio.
DiaSorin is committed to sustainability and ethical practices, with a specific focus on employee well-being, environmental impact, and social responsibility. The company also values diversity and inclusivity, with a workforce that represents over 25 different nationalities.
In 2020, DiaSorin's total revenue was over €870 million. The company continues to grow and expand its reach, with a strong commitment to improving healthcare worldwide.
What is special about the DiaSorin company?
1. Pioneers in the field of immunodiagnostic technologies: DiaSorin was one of the first companies to develop and commercialize immunodiagnostic assays, which use antibodies and other components of the immune system to detect and measure various substances in the body. This has allowed them to be at the forefront of the diagnostic testing industry.
2. Global presence: DiaSorin has a strong global presence, with operations in more than 30 countries and a presence in all major markets, including North America, Europe, and Asia-Pacific. This enables them to reach a wide range of customers and offer innovative solutions to various healthcare challenges worldwide.
3. Extensive product portfolio: The company offers a wide range of diagnostic tests and systems for infectious diseases, autoimmune disorders, and endocrine and metabolic conditions. They have a diverse product portfolio, including automated and semi-automated analyzers, reagents, and software systems, which cater to the needs of various healthcare settings.
4. Focus on research and development (R&D): DiaSorin has a strong commitment to innovation and invests heavily in R&D. They have collaborations with leading academic and research institutions worldwide to develop new and more advanced diagnostic solutions.
5. Strong collaborations and partnerships: The company has established strong partnerships and collaborations with other healthcare companies, academic institutions, and government agencies. These alliances have helped them to bring cutting-edge diagnostic technologies and solutions to the market.
6. Quality and regulatory compliance: DiaSorin maintains a high level of quality and adheres to strict regulatory standards. They have ISO 13485 certification and follow Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP).
7. Commitment to sustainability: DiaSorin is committed to sustainable development and implements environmentally responsible practices in its operations. They also focus on product design and manufacturing processes that reduce waste and energy consumption.
8. Social responsibility: The company has a strong sense of social responsibility and actively participates in various programs and initiatives to improve access to healthcare in underserved communities. They also support employee volunteerism and community service activities.
2. Global presence: DiaSorin has a strong global presence, with operations in more than 30 countries and a presence in all major markets, including North America, Europe, and Asia-Pacific. This enables them to reach a wide range of customers and offer innovative solutions to various healthcare challenges worldwide.
3. Extensive product portfolio: The company offers a wide range of diagnostic tests and systems for infectious diseases, autoimmune disorders, and endocrine and metabolic conditions. They have a diverse product portfolio, including automated and semi-automated analyzers, reagents, and software systems, which cater to the needs of various healthcare settings.
4. Focus on research and development (R&D): DiaSorin has a strong commitment to innovation and invests heavily in R&D. They have collaborations with leading academic and research institutions worldwide to develop new and more advanced diagnostic solutions.
5. Strong collaborations and partnerships: The company has established strong partnerships and collaborations with other healthcare companies, academic institutions, and government agencies. These alliances have helped them to bring cutting-edge diagnostic technologies and solutions to the market.
6. Quality and regulatory compliance: DiaSorin maintains a high level of quality and adheres to strict regulatory standards. They have ISO 13485 certification and follow Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP).
7. Commitment to sustainability: DiaSorin is committed to sustainable development and implements environmentally responsible practices in its operations. They also focus on product design and manufacturing processes that reduce waste and energy consumption.
8. Social responsibility: The company has a strong sense of social responsibility and actively participates in various programs and initiatives to improve access to healthcare in underserved communities. They also support employee volunteerism and community service activities.
Wait! There's more — sign up for free or log in